News

The next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.

An eye-opening study by Precision for Value assesses cancer value frameworks.

Here are three ways HealthPartners’ health plan and care delivery system work together to save customers time and money and improve their experience.

Here’s a look at four changes in the second round of healthcare bill revisions that just weren’t enough to muster up enough votes.

The medication’s ability to reduce inflammation sited as one possible explanation.

Depression is one of the most common diagnosed disorders but providers still have trouble diagnosing and treating these patients.

Study highlights the need for services and research for this understudied population.

An initiative that aims to expand the use of population health strategies has received funding to be used in 500 U.S. cities.

By using a patient-centered, physician-led model of care, Blue Cross Blue Shield (BCBS) of Michigan lowers recidivism and healthcare costs.

Here’s how successful strategy leaders look to industry benchmark data to map out where they want to take their service line, practice or institution.

Payers can facilitate action on the part of physicians to appreciate the growing awareness and financial responsibility of their patients and to better use a shared decision-making approach. Here’s three ways how.

Across the country more states are taking steps to limit patients’ exposure to surprise out-of-network bills.

A West survey has revealing findings about patient satisfaction.

National surveys from Public Agenda, supported by the Robert Wood Johnson Foundation, examine public perceptions of quality in diabetes care, joint replacement and maternity care.

Here are five key strategies to improve care and outcomes for members with advanced illness.

A new study evaluating Humana claims data reveals interesting findings about IVC filter use in managed care.

An Avalere study has interesting findings about payer acceptance of biosimilars.

Novo Nordisk’s DEVOTE study reveals interesting findings.

FDA approves new diagnostic test for non-small cell lung cancer.

Professor in the School for the Science of Health Care Delivery Natalia Wilson, MD, MPH, discusses teaching population health to the next-generation of physicians, and how it will transform care.

Uncover the root causes of why patients become nonadherent and be better positioned to improve the lives of patients and reduce costs through improved health outcomes.

Views on the importance of population health differ depending on how you interact with patients, says the NEJM Care Redesign survey.

A survey from telemedicine provider Carena has interesting findings about virtual clinics.

Analysts discuss how pharmacoeconomics will make a difference in treatment decisions.

An engaged staff is a productive one. Here’s how healthcare executives say they motivate their employees.

Personalized, prescriptive medicine creates higher-value care for patients

Predictive analytics involves extracting information from data and using it to forecast the future based on existing patterns and associations. For managed care organizations, the potential is limitless.

FDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients

FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.

Payers realize value in partnering with pharmacists to manage medication-related complications